A Gram-negative-selective antibiotic that spares the gut microbiome

  30 May 2024

Gram-negative infections are becoming more prevalent, leading to disruption of the gut microbiome. A Gram-negative-specific antibiotic, lolamicin, has been designed and discovered. It targets the lipoprotein transport system, has activity against over 130 multidrug-resistant clinical isolates, and spares the gut microbiome, preventing secondary infections. This selective strategy could be a blueprint for other microbiome-sparing antibiotics.

Further reading: Nature
Author(s): Kristen A. Muñoz et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed